Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO).

Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO).

Item
http://www.wikidata.org/entity/Q44770674
Pazopanib in the management of advanced soft tissue sarcomasSorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)Systemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma.Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group.Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumoursThe Current Status of Solitary Fibrous Tumor: Diagnostic Features, Variants, and Genetics.Emerging therapies for adult soft tissue sarcoma.Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience.Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma.Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.Review of past and present clinical cases with a view to future treatment options.Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
P2860

Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO).

Item
http://www.wikidata.org/entity/Q44770674
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Sorafenib in patients with pro ...... ench Sarcoma Group (GSF/GETO).
@en
Sorafenib in patients with pro ...... dy of the French Sarcoma Group
@nl
type
label
Sorafenib in patients with pro ...... ench Sarcoma Group (GSF/GETO).
@en
Sorafenib in patients with pro ...... dy of the French Sarcoma Group
@nl
prefLabel
Sorafenib in patients with pro ...... ench Sarcoma Group (GSF/GETO).
@en
Sorafenib in patients with pro ...... dy of the French Sarcoma Group
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Sorafenib in patients with pro ...... rench Sarcoma Group (GSF/GETO)
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698